Dossier
neurodegeneration
Coverage of neurodegeneration in the Nexus archive.
Bristol Myers Squibborganization1Nvidiaorganization1Greg Meyersperson1oncologytopic1AI supercomputertopic1foundation modelstopic1Mass General Brighamorganization1Chenlu Gaoperson1National Institutes of Healthorganization1cardiovascular diseasestopic1wrist-worn trackertopic1older adultstopic1correlation vs. causationtopic1
- STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
Bristol Myers Squibb is assembling the largest NVIDIA AI supercomputer in the life sciences industry, following a trend among pharma companies. The company expanded its computing power to develop foundation models for drug candidate interactions in areas like oncology and neurodegeneration.
- More naps, higher risk? Research links daytime sleep to health warnings in aging adults
A study by Mass General Brigham found that excessive daytime napping in older adults is linked to higher mortality risk. Using wrist-worn trackers, researchers observed that longer, more frequent naps—especially in the morning—correlated with increased mortality, suggesting potential early signs of health decline. However, the study notes correlation does not imply causation.